These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 32081246)

  • 1. Impact of postprocedural minimum lumen area on clinical outcome after femoropopliteal drug-eluting stent implantation.
    Haraguchi T; Takahara M; Iida O; Soga Y; Yamaoka T; Fujihara M; Kawasaki D; Ichihashi S; Kozuki A; Sato K; Fujita T
    Vasc Med; 2023 Oct; 28(5):412-421. PubMed ID: 37554116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Looking into the future: Endovascular intervention with intravascular ultrasound.
    Monteleone P; Farr A; Bunte MC
    Vasc Med; 2023 Oct; 28(5):422-424. PubMed ID: 37554115
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of cilostazol on late outcomes after endovascular treatment for occlusive femoropopliteal disease.
    Wang C; Du Z; Zhang M
    J Vasc Surg; 2024 Jul; 80(1):291-292. PubMed ID: 38906666
    [No Abstract]   [Full Text] [Related]  

  • 4. Poor Below Knee Runoff Impacts Femoropopliteal Stent Failure and Fluoropolymer Antithrombotic Effect in Healthy Swine Model.
    Nakamura N; Torii S; Aihara K; Noda S; Kato T; Nakazawa K; Ikari Y; Nakazawa G
    Eur J Vasc Endovasc Surg; 2023 Nov; 66(5):722-729. PubMed ID: 37516380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When Treating Peripheral Artery Disease, Prepare for the Worst, But Hope for the BEST (SFA).
    Biondi-Zoccai G; Corcione N; Giordano A
    JACC Cardiovasc Interv; 2024 May; 17(9):1145-1147. PubMed ID: 38749595
    [No Abstract]   [Full Text] [Related]  

  • 6. Untangling the knot of the best endovascular treatment for femoropopliteal artery disease.
    Giacoppo D
    Int J Cardiol; 2024 Jul; 407():132108. PubMed ID: 38692491
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravascular Ultrasound Guided Totally Percutaneous Femoropopliteal Bypass (PiPer bypass).
    Migliara B
    Eur J Vasc Endovasc Surg; 2023 Dec; 66(6):883. PubMed ID: 37717812
    [No Abstract]   [Full Text] [Related]  

  • 8. Consensus minimum core data elements adapted to peripheral vascular intervention in the drug-eluting era: Consensus report from the Registry Assessment of Peripheral Interventional Devices (RAPID) Pathways "LEAN" working group.
    Black JH; Buckley D; Velezis M; Eldrup-Jorgensen J; Serratore ND; Gutierrez JA; Whatley E; Marmor RA; Bertges DJ; Tcheng JE; Royce S; Malone M; Farb A; Secemsky EA; Parikh SA; Smale J; Jaff MR; White R; Wilgus RW; Krucoff MW
    J Vasc Surg; 2023 Nov; 78(5):1313-1321. PubMed ID: 37524153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorbable Drug Eluting Stents May Bring LIFE to the Treatment of Below the Knee Lesions in Peripheral Arterial Disease.
    Nordanstig J; Mani K
    Eur J Vasc Endovasc Surg; 2024 Aug; 68(2):146-148. PubMed ID: 38762042
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: A look beyond limbs.
    Robbin VE; Dieter EG; Dieter RS
    Cardiovasc Revasc Med; 2024 Jul; 64():42-43. PubMed ID: 38429172
    [No Abstract]   [Full Text] [Related]  

  • 11. Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent.
    Müller-Hülsbeck S; Benko A; Soga Y; Fujihara M; Iida O; Babaev A; O'Connor D; Zeller T; Dulas DD; Diaz-Cartelle J; Gray WA
    Cardiovasc Intervent Radiol; 2021 Mar; 44(3):368-375. PubMed ID: 33225377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Safety and Efficacy of Rotational Atherectomy in Japanese Patients with Peripheral Arterial Disease Presenting Femoropopliteal Lesions: The J-SUPREME and J-SUPREME II Trials.
    Iida O; Urasawa K; Shibata Y; Yamamoto Y; Ando H; Fujihara M; Nakama T; Miyashita Y; Mori S; Diaz-Cartelle J; Soga Y
    J Endovasc Ther; 2022 Apr; 29(2):240-247. PubMed ID: 34510954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical performance of polymer-coated paclitaxel-eluting stent implanted for diffuse and calcified superficial femoral artery stenotic lesions: Insights from a patient on hemodialysis.
    Yoshioka N; Takagi K; Tokuda T; Morita Y; Morishima I
    SAGE Open Med Case Rep; 2021; 9():2050313X211025929. PubMed ID: 34178357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular Response After FP-PES Versus Polymer-Free Paclitaxel-Eluting Stent Implantation in Femoropopliteal Artery Lesions: A Serial Intravascular Ultrasound Study.
    Tomoi Y; Kuramitsu S; Soga Y; Fujihara M; Iida O; Kawasaki D; Ando K
    JACC Cardiovasc Interv; 2020 Feb; 13(4):535-537. PubMed ID: 32081246
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease.
    Zen K; Takahara M; Iida O; Soga Y; Kawasaki D; Nanto S; Yokoi H; Matoba S;
    J Vasc Surg; 2017 Mar; 65(3):720-725. PubMed ID: 28073668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.
    Tsujimura T; Takahara M; Iida O; Soga Y; Katsuki T; Fujihara M; Kawasaki D; Kozuki A; Mano T
    J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Polymer-Free Paclitaxel-Eluting Stent Versus a Bare-Metal Stent for De Novo Femoropopliteal Lesions: The BATTLE Trial.
    Gouëffic Y; Sauguet A; Desgranges P; Feugier P; Rosset E; Ducasse E; Kaladji A; Salomon du Mont L; Pernès JM; Commeau P; Lermusiaux P; Leclere B; Guyomarc'h B; Hoffmann CT; Maurel B
    JACC Cardiovasc Interv; 2020 Feb; 13(4):447-457. PubMed ID: 32081238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Femoral-popliteal peripheral artery disease: From symptom presentation to management and treatment controversies.
    Krawisz AK; Raja A; Secemsky EA
    Prog Cardiovasc Dis; 2021; 65():15-22. PubMed ID: 33592208
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.